Cyclic polypeptide compound and use thereof
AssigneeBivision Pharmaceuticals, Inc.
InventorsEric Yanjun WANG, Jinqiu HE, Haihua HU, Kevin Yu WANG, Yueguang SUN, Jian ZHAN, Yaoming YU
Life of this patent
Estimating the term…
Loading patent…
AssigneeBivision Pharmaceuticals, Inc.
InventorsEric Yanjun WANG, Jinqiu HE, Haihua HU, Kevin Yu WANG, Yueguang SUN, Jian ZHAN, Yaoming YU
Estimating the term…
Provided are a cyclic polypeptide compound and the use thereof, and specifically disclosed are a cyclic polypeptide compound A and a cyclic polypeptide compound B. The cyclic polypeptide compound A is a compound formed by ion chelation of a compound X and a therapeutic radionuclide. The cyclic polypeptide compound B is a compound formed by ion chelation of a compound X and a diagnostic radionuclide. The compound can be used for diagnosis and treatment of FAP-related or mediated tumors, has high tumor uptake and long retention time, and has a wide application prospect.
1-6. (canceled)
A compound X-6 or a pharmaceutically acceptable salt thereof,
8-19. (canceled)
A compound or the pharmaceutically acceptable salt, wherein the compound has a structure as shown in any one of the following:
Dependencies are inferred from the claim text.